Российский научный центр восстановительной медицины и курортологии



страница6/6
Дата28.11.2017
Размер1.51 Mb.
ТипДиссертация
1   2   3   4   5   6

Шестакова М.В., Брескина О.Ю. Инсулинорезистентность: патофизиология, клинические проявления, подходы к лечению // Consilium medicum. - 2002. - Т 4. -№ 10. – С. 52-55.


  • Шляхто Е.В. Патогенез и прогрессирование ГБ с позиции нейрогенных механизмов.// Кардиоваскулярная терапия и профилактика, 2003. - № 3. – С. 8-13.

  • Шулутко Б.И. Артериальная гипертензия. –СПб. РЕНКОР, 2001. – 382 с.

  • Шустов С.Б. Функциональное состояние прессорных и депрессорных звеньев симпатико-адреналовой системы у больных мягкой артериальной гипертонией. // Кардиология, 2000. –Т. 41. -№ 3. –С.50-51.

  • Яковлев П.А. Реакция организма на действие хлоридной натриевой бромйодной воды в условиях бассейна, ванн и в сочетании бассейна с ваннами: Автореф. дисс. … канд. мед. наук. – Пермь, 1974 – С.23.

  • Яременко М.С., Бутусова И.А., Попович И.Л., Лахин П.В. К вопросу о дозировании питьевых минеральных вод // Вопр. курортол. - 1989. - № 4. - С. 59-60.

  • Ясницкий П.А. Терапия бромйодными ваннами в бальнеологическом санатории Усть-Качка // В кн. "Научные работы Пермского мединститута". - Пермь. - 1955. - С. 167-17I.

  • Abate N., Garg A., Peshock R.M. et al. Relationship of generalizad and regional adiposity to insulin sensitivity in men // J. Clin. Invest. -1995. -Vol. 96. -P. 88-98.

  • Amery A., Birkenhager W., Brixho P. et al. Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on High Blood Pressure in the Elderly (EWPHE). // Postgrad. Med. J. -1986. –v. 62 -Р. 919-924.

  • Anderson E. A., Mark A. L. The vasodilator action of insulin: inmlication for the insulin hypothesis of hypertension. Hypertension 1993; 21:136 – 141.

  • Anderson K.M., Castelly W.P. and Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA. -1987. – v. 257. – P. 216.  

  • Arrieta F., Rodriguez E., Ramos F. et al. Body mass index influence in the insulin action mechanisms comments // Ann.Med.Intrna. -1998 . -Vol. 15. -P. 406-410.

  • Assman G., Von Eckardstein A., Funke H. Disorders of the high density lipoprotein metabolism // Lipid metabolism disorders and coronary heart disease / Ed. By G. Assman. – Munich: MMV Medizin Verlag, 1993. – P. 25.

  • Austin M.A., Hokanson J.E., Edvards K.L. Hypertriglyceridemia as a cardiovascular risk factor // Am. J. Cardiol. -1998. -v. 81. –P. 7B–12B.  

  • Avogaro A., Beltramello P., Marin T., et al. Insulin action and glucose metabolism are improved by gemfibrozil in hypertriglyceridemic patients // Atherosclerosis. – 1995. –v. 113. – P. 117-124.

  • Avogaro P., Crepaldi G., Enzi G., Tiengo A. Association of hyperlipidemia, diabetes mellitus and mild obesity // Acta Diabetol. Lat. -1967. -№ 4. –P. 572-590.

  • Baillie G.M., Sherer J.T., Weart C.W. Insulin and coronare artery disease: is syndrome X the unifying hypothesis? Review // Annals of pharmakotherapy. -1998. -Vol. 32. -№ 2. -P. 233-247.

  • Bjorntorp P. Endocrine abnormalities in obesity // Diabetes Rev. -1997. -Vol. 5. -P. 52-68.

  • Bonner G. Hyperinsulinemia, insulin resistence and hypertension. Review // J.Cardiovasc. Pharmacol. -1994. -Vol. 24. Suppl. 2. -P. 839-849.

  • Brunelli C., Spallarossa P., Cordera R. Caponnetto S. Hyperinsulinemia and cardiovascular risk. Review // Cardiologia. -1994. -Vol. 39. -№ 12. Suppl.1. –P. 163-168.

  • Caro J.F. Insulin resistance in obese and nonobese men // J. Clin. Endoriniol. and Metab. -1991. –v.73. – P. 691-695.

  • Castelly W. Cholesterol and lipids in the risk of coronary artery disease: the Framingham Heart Study // Can. J. Cardol. -1988. - № 4 (Suppl A). – P. 5A–10A.

  • Chen W., Bao W., Begum S. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X. Diabetes Jun-2000.

  • De Fronzo R.A., Ferranini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic disease. Diabetes Care, 1991; 14: 173-194.

  • Despers J.P., Lamarsbe B., Maurige P. at al. Hiperinsulinemia as an independent factor for ischemic heart disease //N. Eng. J. Med. - 1996, 334, 952

  • Fonfbonne A., Charles M.A., Thibull N. et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study. 15-year follow-up. // Diabetologia – 1991. -V. 34.

  • Fracchini F., Chen Y.-D., Hollenbeck C.B. et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uzic acid ckearance and plasma uric acid concentration // JAMA. -1991. -Vol. 266. -P. 3008-3011.

  • Gillman M., Kannel W., Belanger A., D’Agostino R. Influence of heart rate on mortality among persons with hypertension: The Framingam study Am Heart J 1993; 125: 1148-54.

  • Giugliano D., De Rosa N., Di Maro G., et al. Metformin improves glucose, lipid metabolism and reduces blood pressure in hypertensive, obese women. Diabetes Care, 1993; 16: 1387-1393.

  • Gleerup GVJ, Winther K. Platelet function and fibrinolytic activity during

  • Grundy S Hypertriglyceridemia, insulin resistance and the metabolic syndrome. Am .J .Cardiol., 1999; 83 (9B): 25F–29F.  

  • Haffner P.A., Valdez R.A., Hazuda H.P., et al. Prospective analysis of the insulin- resistance syndrome (Syndrome X ). Diabetes 1992; 41: 715-722.

  • Horky K. Humoral mechanisms in the pathogenesis of arterial hypertension with emphasis on the renin–angiotensin–aldosterone system and natriuretic substances // Vnitr. Lek. – 1989; V. 35 (3). – P. 219–225.

  • Horlick L. Dyslipidemia and metabolic factors in the genesis of heart attack and stroke // Health Reports. –1994. –Vol. 6, № 1. -P. 94–99.

  • Jarrett R. In defence of insulin: a critique of Syndrom X // Lancet.-1992. -Vol. 340. -P.469-483.

  • Kaplan N.M. The deadly quarted and the insulin resistance syndrome: an historical overview // Hypertens v Res., 1996, 13, 9-11

  • Kario К, Nafo N, Kayaba K, Saegusa T, Matsuo H, Goto T. Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study. // Atherosclerosis, Thrombosis and Vascular Biology. -1996: 16: 270-274.

  • Kaski J., Russo G. Cardiac syndrome X: an overview. Hosp. Pract. Feb. – 2000.

  • Mamedov M.N., Perova N.V., Oganov R.G. Lipid abnormalities in Russian hypertensive patients: role in metabolic syndrome atherogenicity.// In: Advances in Lipoprotein and Atherosclerosis Research, Diagnostics and Treatment. Proc. 9th Intern. Dresden Lipid. Symp., 1997: 186-191.

  • Matthaei S., Stumvoll M., Kellerer M. et al. Pathophysiology and Pharmacological Treatment of Insulin Resistance // Endocrine Rev. -1999. -Vol. 21, № 6. -P. 585-618.

  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher D.F, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. // Diabetologia. - 1985. - Vol. 28. -P. 412-419.

  • Metelskaya V., Serdyk A., Mamedov M., Perova N., Oganov R. Insulin resistance markers for coronary heart disease high risk subjects selection. // In: Advances in Lipoprotein and Atherosclerosis Research, Diagnostics and Treatment. Proc. 9th Intern. Dresden Lipid Symposium. Fischer G. (ed)., 1997: 192-195.

  • Nagi D., Yudkin J.S. Effects of metformin on insulin resistance, risk factors for cardiovascular disease and plasminogen and plasminogen activator inhibitor in NIDDM subjects. // Diabetes Care, 1993; 16: 621-629.

  • Neel J.V. Diabetes Mellitus: A "Thrifty" Genotype Rendered Detrimental by "Progress"? // Am. J. Hum. Genet., 1984 -Vol. 14. -№ 4. -P. 353-362.

  • Olefsky J., Reaven G. Insulin binding in diabetes relationship with plasma insulin level and insulin sensitivity // Diabetes. -1997. -Vol. 26. -P. 680-688.

  • Olefsky J.M., Farquar J.W., Reaven G.M. Reappraisal of the role of insulin in hypertriglyceridemia. Am. J. Med., 1974; 57: 551-560.

  • Palatini P. Sympathetic Overactivity in Hypertension: A Risk Factor for Cardiovascular Disease. Current Hypertens Reports 2001; 3 (Suppl 1): 53-9.

  • Park Y.W. Zhu S, Palaniapan L., et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population // Arch. Intern. Med. 2003,163 (4):427-436

  • Perova N., Mamedov M., Metelskaya V., Olferiev A., Oganov R. Cardiovascular global risk in hypertensive Russian men with clustering of metabolic syndrome abnormalities.// Abstr. 70th EAS Congress, Geneva (Switzerland), Sept. 6-9th, 1998; -P. 47.

  • Plans P., Espunas I., Romero N. et. al. The association between arterial hypertension, obesity and pypercholesterolemia in a sample of the adult population of Catalonia // Anal. Med. Intern., – 1994. – Vol. 11, № 6. – P. 278–284.

  • Pyorola К, Savolainen S. Insulin as a coronary heart disease risk factor: relationship to other risk factors and predective value during nine and half years follow up of the Helsinki policemen study population. //Acta Med Scand. 1985; 701: 38-52.

  • Rapoport B. et al. On the mechanism of inhibition by iodine of the thyroid adenylate cyclease response to thyrotropic hormone // Endocrinol., 1976; №29: 11.

  • Reaven G M Metabolic syndrome // Circulation. 2002, 106: 286-288.

  • Reaven G.M. Banting Lecture 1988. Role of insulin resistance in human disease // Diabetes. - 1988. - Vol. 37. - P. 1595-1607.

  • Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.

  • Reaven G.M. Role of insulin resistance in human disease: syndrom X // In:

  • Reaven GM, Lithell H, Landsberg L. Hypertention and associated metabolic abnormalities the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381

  • Reaven GM. Chen Y-DL. Jeppesen J et el Insulin resistance and hypertriglyceridemia in an individuals with smal, dense low density lipoprotin particles //.J. Clin. Invest., 1993; 92: 141.  

  • Resnick L.M. Ionic basis of hypertension, insulin resistance, vascular disease and related disorders.// Am. J. Hypertens. 1993; № 6: S123-S134.

  • Russel James C., Ahuja Sunil K., Manickavel V. et al. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat// Arterioscl. - 1987. - Vol.7, № 6. -P. 620-626.

  • Russo, Kaski J. C. Hospital practice: Cardiac syndrome X: Overview; 2000;2.

  • Shimamoto K., Kirata A., Masatoda F. et al. Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive pations // Hypertension. -1994. -Vol.23. -P.129-136.

  • Sowers J.R., Standley P.R., Ram J.L. et al. Hyperinsulinemia, insulin resistance and hyperglycemia: contributing factors in pathogenesis of hypertension and atherosclerosis. Am. J. Hypertens. 1993; № 6: S.260-S270.

  • Spielberger C.D., e.a. Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychological Press, 1983.

  • Stampler J, Stampler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. Arch Intern Med. 1993; 153:598-615.

  • Stem M.P. Diabetes and cardiovascular disease. The "common soil" hypotehesis. Review // Diabetes. 1995 apr. Vol. 44. № 4. 369-374.

  • Taskinen M.R. Strategies for the diagnosis of metabolic syndrome. Current Opinion in Lipidology. 1993; 4: 434-443.

  • Tiengo A., Avogaro P., Del Prato S. Pathogenesis and therapy of plurimetabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 1996; 6: 187-192.

  • Timar O. Metabolic syndrome X: a review. Can. J. Cardiol Jun.-2000. –Р. 38-44.

  • Tobey T.A., Greanfild M., Kraemer F. et al. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic men. Metabolism, 1981; 30: 165-171.

  • Tschoepe D. Diabetes // In: 4th Int.Symp. on Multiple Risk Factors in Cardiovascul. Dis.-Washington,1997.-P.25 (Abstr.).

  • Vaccaro O, Riccardi G. Blood pressure, insulin and associated metabolic abnormalities in non diabetic individuals. Nutr Metab Cardiovasc Dis 1997; 7:76-80.

  • Vaiek J. Insulin resistence, hypertension and atherosclerosis // Casopis Lekaru Ceskych. 1994. Vol. 133. N15. P.451-454. Aug.1.

  • Vanhala M., Kumpusalo E., Takala J. Metabolic syndrome; a cluster of hypertension, dislipidemia and hyperinslinemia the association with obesity. / In: XVII Congress of the European Sosiety of Cardiology. August, 20-24, 1995, Amsterdam, Netherlands. CD Conifer Information System: P.488.

  • Veterans Administration Cooperative Study Group on Hypertensive Agents. JAMA 1970;213:1143-52

  • Walton C., Lees B., Crook D. e.a. Relationships between insulin metabolism, serum lipid profile, body fat distribution and blood pressure in healthy men // Atherosclerosis. 1995. Vol. 118. P. 35-43.

  • Weaver J.U., Koppdman P.G., Hitman G.A. Central obesity and hyperinsulinemia ш women are associated with polymorphism in the 5" flanking region of the human insulin gene // Eur. J. Clin. Investig. 1992 apr. Vol. 22. N4. P. 265-270.

  • Williams B. Insulin resistance: the shape of things to come.//Lancet.- V. 344 -1994.

  • York E., Mitchell R., Graybiel A. Cardiovascular epidemiology exercise and health: 40-year follow up of the US Navy's "1000 Aviators"// ASEM, 1986, v. 57, N 6, p. 597–599

  • Yudkin J. Sucrose, insulin and coronary heart disease // Am. Heart J. 1970. Vol.80. P. 844-846.

  • Zang S. L., Chen X., Hsieh Т. J. et al. Hyperflycemia induces insulin resistance on angiotensinogen gene expression in diabetic rat kidney proximal tubular cells. J Endocrinol 2002; 172; 2; 333–334.

    Каталог: upload -> dissertacii -> Jedelbieva
    dissertacii -> Диссертация на соискание ученой степени доктора медицинских наук Научные консультанты: доктор медицинских наук, профессор И. А. Курникова (Москва)
    dissertacii -> Гирудотерапия в комплексном лечении гипертонической болезни 14. 03. 11 Восстановительная медицина, спортивная медицина, лечебная физкультура, курортология и физиотерапия
    dissertacii -> Панченко дина Серафимовна патогенетическое обоснование рефлексотерапии в коррекции сухой кожи лица у женщин
    dissertacii -> Диссертация на соискание ученой степени доктора медицинских наук Научные консультанты: доктор медицинских наук, профессор И. А. Курникова (Москва)
    dissertacii -> Фотосенсорная стимуляция и акупунктура в терапии эректильной дисфункции у больных с психовегетативным синдромом 14. 03. 11 восстановительная медицина, спортивная медицина, лечебная физкультура, курортология и физиотерапия
    Jedelbieva -> Российский научный центр восстановительной медицины и курортологии


    Поделитесь с Вашими друзьями:
  • 1   2   3   4   5   6


    База данных защищена авторским правом ©vossta.ru 2019
    обратиться к администрации

        Главная страница